AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04978935 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Care protocol
Description: Before starting the application, the investigator (DS) will fill out the Introductory Characteristics Form of all patients, the Pre-thoracotomy Pulmonary Function Test (PFT) section of the Patient Results Form. The PFT section will be re-evaluated on the 1st, 5th day and on the day of discharge after thoracotomy.~Nursing interventions will be applied to the study group (n=40), starting from the 0th day (the first day spent in the intensive care unit) after the thoracotomy in line with the prepared care protocol application steps until discharge. Care protocol consists of patient's position, mobilization, use of spirometer and shoulder exercises.
Study NCT05150418 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxygen gas
Description: Oxygen 15 l/min
Study NCT05356572 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Investigational Skin Preparation Device
Description: Removal of hyperkeratotic skin with Investigational Skin Preparation Device
Study NCT05356572 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: GMDN 47102 / Electrode Skin Abrasive Pad
Description: Removal of hyperkeratotic skin with Abrasive Pad for Skin Preparation
Study NCT05356572 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: UMDNS 13-230 / Biopsy punch (Dermal Curette)
Description: Removal of hyperkeratotic skin with Disposable Dermal Curette
Study NCT04765098 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Description: Tamoxifen 20 mg daily for 3 days then 20 mg BID for 3 days then increase by 20 mg daily every 3 days until 100 mg BID continuously
Study NCT04765098 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Etoposide
Description: etoposide 50mg/m2 daily
Study NCT06498895 — intervention group
Intervention type: RADIATION
Intervention: lung ultrasound
Description: Lung ultrasound score will be done within one hour of admission,12 hours post admission then 24 hours in intensive care unit,follow up of patients will continue for 72 hours .~a complete lung ultrasound evaluation will be performed using low frequency curved probe (2MHz-5MHz) according to the lung ultrasound score . The external lung fields will be examined by longitudinal and transverse plane scans, dividing the surface of the thorax into 12 zones: 6 on the right (anterior: upper R1 and lower R2; lateral; upper R3 and lower R4; posterior: upper R5 and lower R6) and 6 on the left side (front: upper L1 and lower L2; lateral: upper L3 and lower L4; rear: upper L5 and lower L6). LUS assigns 0 points to A lines or \< 2 separate B lines plus regular sliding; 1 point with lines B ≥ 3 or spaced focal points plus regular sliding; 2 points with coalescing B lines, and 3 points to pulmonary consolidations for each zone with a score ranging from 0 (normal lungs) to 36 (worst case scenario)
Study NCT04332666 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Angiotensin 1-7
Description: endogenous peptide dilution: angiotensin-(1-7) 0.5 mg / L NaCl 0.9%
Study NCT04332666 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebos
Description: infusion of NaCl 0.9% without diluted peptide in it
Study NCT05150418 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Air
Description: Room air 15 l/min
Study NCT05375019 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Positive discipline program
Description: The intervention group was provided with 8 weekly sessions of a 90 minutes positive discipline program
Study NCT05375019 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: active control group
Description: free interaction group consisting of topics determined by the families.
Study NCT04933786 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital Health Nudging
Description: Short daily text messages with information and motivation concerning physical activity.
Study NCT04252209 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: natural herbs of coconut, aloe vera, and pepperint
Description: mixture of herbal oils of coconut, peppermint, aloe vera
Study NCT04252209 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: carboxy methyl cellulose
Description: a moisturizing gel contained 3%carboxy methyl cellulose, 3% peppermint essential oil, 10% propylene glycol, 0.1% potassium sorbate, and water up to 100%.
Study NCT06087380 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: auricular acupressure
Description: Auricular pressure The experimental group commenced auricular acupressure intervention post-surgery. Questionnaire assessments and heart rate variability measurements were conducted in the experimental group on the first, second, third, and fourth days before discharge.
Study NCT06087380 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: standard ward care
Description: standard ward care
Study NCT06087380 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: standard ward care
Description: standard ward care
Study NCT05269186 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual reality software
Description: The patient will undergo a 20-minute virtual reality session before the planning CT scan
Study NCT05014152 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Q-temp-w1
Description: Q-temp-w1 is a contact type body temperature patch developed by Quanta Computer Co., Ltd. It is mainly used to measure the body temperature of the human body. It can be used for general body temperature measurement, home temperature measurement records and medical tracking.
Study NCT05014152 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Omron thermometer(MC-171W)
Description: Omron thermometer(MC-171W) is mainly used to measure the body temperature of the human body. The reference temperature patch used in this study is the OMRON thermometer, model: MC-171W.
Study NCT04692922 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: MRI
Description: MRI will include structural sequences (e.g., T1 weighted imaging, T2 weighted imaging, T2 FLAIR, diffusion weighted imaging with apparent diffusion coefficient, susceptibility weighted imaging, and diffusion tensor imaging). Using the structural sequences we will make note of the types of brain lesions (e.g., ischemic stroke, hemorrhage, hypoxic-ischemic brain injury), and the locations of these brain lesions. MRI will also include fMRI under three conditions: while the patient is at rest (to evaluate resting state functional connectivity), while the patient is exposed to auditory stimuli (to evaluate passive fMRI responses to stimuli), and while the patient is asked to follow commands (to evaluate active fMRI responses to tasks).
Study NCT04692922 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: EEG
Description: The EEG will include resting, stimulus-based, and task-based assessments of brain function.
Study NCT05470400 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: FP conjugate vaccine (25 mcg)
Description: FP8v1-rTTHC (FP conjugate vaccine) is an HIV-1 fusion peptide conjugated to recombinant tetanus toxoid heavy chain fragment C (rTTHC) via sulfo-SIAB chemical linker.~Study vaccines will be admixed with Adjuplex adjuvant and administered intramuscularly (IM) via needle and syringe in two injection sites.
Study NCT05470400 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: FP conjugate vaccine (200 mcg)
Description: FP8v1-rTTHC (FP conjugate vaccine) is an HIV-1 fusion peptide conjugated to recombinant tetanus toxoid heavy chain fragment C (rTTHC) via sulfo-SIAB chemical linker.~Study vaccines will be admixed with Adjuplex adjuvant and administered intramuscularly (IM) via needle and syringe in two injection sites.
Study NCT05470400 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Trimer 6931 (100 mcg)
Description: HIV-1 Trimer 6931 (Trimer 6931) is a synthetic soluble HIV-1 envelope product that consists of an HIV-1 envelope (Env) trimer variant, derived from consensus clade C sequence (ConC).~Study vaccines will be admixed with Adjuplex adjuvant and administered intramuscularly (IM) via needle and syringe in two injection sites.
Study NCT05470400 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Trimer 6931 (200 mcg)
Description: HIV-1 Trimer 6931 (Trimer 6931) is a synthetic soluble HIV-1 envelope product that consists of an HIV-1 envelope (Env) trimer variant, derived from consensus clade C sequence (ConC).~Study vaccines will be admixed with Adjuplex adjuvant and administered intramuscularly (IM) via needle and syringe in two injection sites.
Study NCT05470400 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Trimer 4571 (200 mcg)
Description: HIV-1 Trimer 4571 (Trimer 4571) is a synthetic soluble HIV-1 envelope product that consists of an HIV-1 envelope (Env) trimer variant, derived from clade A, strain BG505.~Study vaccines will be admixed with Adjuplex adjuvant and administered intramuscularly (IM) via needle and syringe in two injection sites.
Study NCT05470400 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Trimer 4571 (100 mcg)
Description: HIV-1 Trimer 4571 (Trimer 4571) is a synthetic soluble HIV-1 envelope product that consists of an HIV-1 envelope (Env) trimer variant, derived from clade A, strain BG505.~Study vaccines will be admixed with Adjuplex adjuvant and administered intramuscularly (IM) via needle and syringe in two injection sites.
Study NCT05815602 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ebastine
Description: Randomized subjects will administer 4 pills of study medication per day during 12 weeks.~Daily administration schedule consists of taking 2 pills in the morning (1 verum, and 1 placebo). In the evening, subjects will take a second dose of both verum and placebo.
Study NCT05815602 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Duspatalin
Description: Randomized subjects will administer 4 pills of study medication per day during 12 weeks.~Daily administration schedule consists of taking 2 pills in the morning (1 verum, and 1 placebo). In the evening, subjects will take a second dose of both verum and placebo.
Study NCT05733936 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: rehabilitation protocol
Description: rehabilitation protocols after ACLR have been described, aiming to improve muscle strength and knee stability through muscle strengthening exercises in addition to exercises to improve joint proprioception
Study NCT04863378 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Walking conversational reminiscence
Description: Triadic walking with prompted conversational reminiscence
Study NCT05926934 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Experimental: Single strand β-Ti fixed retainer
Description: All 90 patients between 13-30 y.o. treated with fixed orthodontic appliances (Roth 0.018'' slot at their final finishing stage) on at least between their lower first premolars and with no lower anterior teeth crowding (total irregularity index score = 0) and no need of removable retention appliances on their lower teeth, were randomly assigned to one of the three experimental groups.
Study NCT05926934 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Experimental: SS fixed retainer
Description: All 90 patients between 13-30 y.o. treated with fixed orthodontic appliances (Roth 0.018'' slot at their final finishing stage) on at least between their lower first premolars and with no lower anterior teeth crowding (total irregularity index score = 0) and no need of removable retention appliances on their lower teeth, were randomly assigned to one of the three experimental groups.
Study NCT05926934 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Experimental: Twisted fixed retainer
Description: All 90 patients between 13-30 y.o. treated with fixed orthodontic appliances (Roth 0.018'' slot at their final finishing stage) on at least between their lower first premolars and with no lower anterior teeth crowding (total irregularity index score = 0) and no need of removable retention appliances on their lower teeth, were randomly assigned to one of the three experimental groups.
Study NCT05625204 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Center based attention (stretching only) control
Description: Center based attention (stretching only) control
Study NCT05625204 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Center based HIIT
Description: Center based HIIT
Study NCT05625204 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home based HIIT
Description: Home based HIIT
Study NCT06488274 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: New infant formula
Description: The new formula will be given to infants during the 4-month study period.
Study NCT05733936 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: rehabilitation protocol
Description: rehabilitation protocols after ACLR have been described, aiming to improve muscle strength and knee stability through muscle strengthening exercises in addition to exercises to improve joint proprioception
Study NCT04247750 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sirolimus 0.5 mg
Description: Daily administration of 1 or more tablets
Study NCT06238245 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamid
Description: ATG (anti-thymocyte globulin, rabbit; 5 mg/kg, day -5 to -2) was used in matched sibling donor-HSCT. ATG (1.5 mg/kg, day -5; 2.5 mg/kg, day -4; mathematical function was then exploited to determine the total targeted ATG dose on day -3 to -2 based on concentrations of active ATG on day -5 to -4) was used in both haploidentical donor-HSCT and mismatched unrelated donor-HSCT. Reduced-dose PTCy (two doses of 14.5 mg/kg Cy was given on days +3 and +4 post-HSCT) was used of GVHD prophylaxis.
Study NCT05500924 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention group
Description: 5 sets of functional activities each will be repeated for 3 times , while the therapist is performing mulligan mobilization techniques Sit to stand Squat Stand to sit Stairs stepping Bridging
Study NCT06357949 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: High-intensity laser
Description: All patients will receive a rehabilitation program consisting of stretching, strengthening, balance, and walking exercises targeting the lower extremities for 45 minutes, 5 days a week, for 6 weeks. Walking training will initially begin on level ground and gradually progress to different levels and surfaces.~High-intensity laser will be applied continuously in biostimulation mode 3 days a week, once a day, for a total of 9 sessions over 3 weeks
Study NCT06357949 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham laser
Description: The same procedure will be followed, but sham laser will be applied at 0 j/cm2 for 10 minutes.
Study NCT04494633 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical Encounters Medical School 3D Simulation
Description: A 3D simulation related to coping with the stresses of medical school and burnout.
Study NCT04966637 — intervention group
Intervention type: OTHER
Intervention: COPD cohort
Description: as this a retrospective descriptive study no intervention will be administered to study participants
Study NCT06081998 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Histamine
Description: Histaminergic itch will be evoked by a 1% histamine solution. A droplet of histamine solution will be placed on the predetermined area on the forearm, and the SPT lancet will be pierced through the histamine with 120 g of pressure for 1-2 seconds
Study NCT06081998 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cowhage
Description: 25 spicules will be inserted in the centre of the predefined skin area on the mandibular area. The spicules will be gently rubbed for 15-20 seconds in circular motion to facilitate epidermal penetration
Study NCT06512649 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Early intervention
Description: 90-minute parent-coaching session once a week for 6 months with an expert developmental therapist, supported by a child neuropsychiatrist or psychologist. A parent will always be present and actively involved in the intervention. The intervention is individualized and tailored to each child's needs and identifies with caregivers the ways to embody objectives in daily life.
Study NCT06512649 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Active monitoring
Description: 90-minute session once a month for 6 months. Sessions will be performed by an expert developmental therapist, supported by a child neuropsychiatrist or psychologist. A parent will always be present and actively involved in the intervention.
Study NCT06063408 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Functional Therapy
Description: Cognitive functional therapy (CFT) is a novel intergraded behavioral approach for individualizing the management of spinal pain, targeting the bio-psycho-social factors of rehabilitation, and enabling the patient to self-manage the condition.~CFT lies within the broad spectrum of the biopsychosocial approach for the management of spinal pain. CFT uses a multidimensional clinical reasoning framework with aim to enable the clinician to identify modifiable components of the condition, evaluate patients' behavioral responses to pain, and compose and drive a tailored rehabilitation program mainly based on self-management. The intervention is comprised by the interplay on making sense of pain, exposure with control, and lifestyle change.
Study NCT06063408 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Therapy
Description: Each individual session involve a combination of pain management with electrotherapy, massage and relaxation techniques. Also include some posture exercise these will be targeted on body alignment to the neutral position, and strengthening the whole neck area. strengthening program will be include isometrics on all cervical movements with a band which progressively increase the resistance of the band by change it and process to exercise against the band resistant. The relaxation/mindfulness component will take place at the end of each class and will involve breathing and relaxation of the body.
Study NCT05944991 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Olive oil message
Description: Message of olive oil 2 times daily
Study NCT05098457 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GP0112
Description: Injectable gel
Study NCT05098457 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Restylane Lyft Lidocaine
Description: Injectable gel
Study NCT06101277 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ablative local therapy
Description: Stereotactic ablative radiotherapy (SABR) or interventional radiology (IR) ablation therapy
Study NCT05175924 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nanpharmacological method
Description: Virtual Reality
Study NCT04601233 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XYOSTED 75 milligram (mg) in 0.5 ML Auto-Injector
Description: Self injection testosterone treatment
Study NCT04475250 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tetragraph (TM) NMT Monitor
Description: TetraGraph is a unique, EMG-based portable device for quantitative (objective) monitoring of neuromuscular function. It is a precise and easy to use tool for monitoring depth of block, ensuring adequate recovery of muscle function, and aiding the clinician to reduce the incidence of residual block.
Study NCT05857462 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Post-admission FICB
Description: Post-admission supra-inguinal FICB in hip fracture patient with 0.33% bupivacaine 30 ml
Study NCT04786964 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cosibelimab
Description: IV infusion
Study NCT04786964 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cisplatin
Description: IV infusion
Study NCT04786964 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: IV infusion
Study NCT04786964 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: IV infusion
Study NCT04786964 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: IV infusion
Study NCT04786964 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pemetrexed
Description: IV infusion
Study NCT05619016 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: [68Ga]Ga-ABY-025 PET
Description: \[68Ga\]Ga-ABY-025 PET: Each patient in Cohort 1 will be imaged with a PET/CT twice using the radiolabeled investigational product ABY-025 as a tracer. At the time of injection, a 45-minutes long dynamic scan will take place over a pre specified region of interest. Three hours after injection a full body PET scan followed by a CT scan will be performed.
Study NCT05619016 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Biopsy and analysis of HER2 expression
Description: Biopsy: Within 3 days after the first ABY-025-PET a tissue sample from at least one metastasis >10 mm available for biopsy, preferably shallow lymph nodes, will be analyzed for HER2 expression through immunohistochemistry- (IHC) and in situ hybridization- (ISH) analysis in patients with GEAC and HER2low mBC.
Study NCT06042439 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 6 weeks of exercise training (Pre-training)
Description: handgrip and treadmill walking 4 days per week
Study NCT03239236 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Rapid sequence induction t-RSI
Description: Preoxygenation via face mask, no ventilation with no PEEP until intubation
Study NCT03239236 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Rapid sequence induction m-RSI-PEEP
Description: Preoxygenation via facemask with PEEP of 10 mbar. PEEP will be continued until intubation.